Spearheading the First-in-Class Treatment for Alopecia Areata through JAK Inhibition
Time: 2:00 pm
day: Day 1 PM - Track B
Details:
- Comprehending how the underlying mechanism for alopecia makes JAKis good candidates for therapy
- Discussing the biomarkers of treatment response and patient selection
- Addressing the safety concerns and translating our current understanding to best inform patients